首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1566952

膽紅素計市場：按產品、適應症、年齡層和最終用戶：2024-2033 年全球機會分析和產業預測

Bilirubin Meters Market By Product , By Indication By Age Group By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033

出版日期: 2024年07月10日 | 出版商:

Allied Market Research | 英文 280 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023年膽紅素測量儀器市場價值為12億美元，預計2024年至2033年複合年成長率為7.6%，到2033年將達到25億美元。

膽紅素測定儀是一種手持式醫療設備，主要用於測量新生兒血膽紅素濃度。膽紅素水平升高會導致黃疸，黃疸是嬰幼兒的常見病症，如果不及時治療，可能會導致嚴重的健康問題，包括腦損傷。這些儀器提供了一種非侵入性、快速且準確的方法來監測膽紅素水平，從而實現早期檢測和治療。因此，它們在新生兒護理中發揮著重要作用，幫助醫療保健專業人員就是否需要進一步檢查和干涉措施做出明智的決定。

全球膽紅素檢測儀市場的成長是由於新生兒黃疸盛行率的驚人上升以及對新生兒黃疸的早期診斷和治療以預防馬蘇等併發症的日益重視所推動的。根據 Science Direct 2024 年 1 月發表的一項研究，全球每年約有 110 萬名新生兒患有高膽紅素血症，超過 2,000 萬名新生兒面臨高膽紅素血症相關併發症的風險。此外，容易患黃疸的早產兒數量不斷增加，也增加了對膽紅素測量設備的需求。這是因為膽紅素計在新生兒加護病房中至關重要，因為早產兒通常需要更密切的監測。根據世界衛生組織 (WHO) 統計，2020 年約有 1,340 萬名早產兒。此外，旨在降低嬰幼兒死亡率和改善新生兒健康的政府措施不斷增多，正在推動膽紅素測量設備的採用，這是全球市場的主要驅動力。使用經皮方法透過皮膚測量膽紅素水平的非侵入性膽紅素測量設備的轉變是當前的趨勢，正在加強全球市場的成長。這些設備減少了抽血的需要，減輕了新生兒的抽血壓力，並提高了醫療保健提供者的效率。儘管非侵入式數位膽紅素測量儀具有顯著的優點，但其高成本對採用造成了障礙，特別是在低收入地區和小型醫療機構，從而阻礙了市場的成長。此外，醫療保健專業人員缺乏對定期膽紅素監測和使用膽紅素測量設備的重要性的認知和培訓，這是市場的主要阻礙因素。為此，製造商正在專注於開發可攜式和現場膽紅素測量儀，這些測量儀結構緊湊、易於使用，並且設計用於各種環境，包括醫院、診所，甚至是我正在做的居家醫療。它。此外，感測器技術的創新使得膽紅素測量儀器變得更加準確和可靠。這些進步包括使用頻譜感測器和演算法，即使是深色皮膚的嬰兒也能進行精確測量，解決了舊設備先前的局限性。此類新興市場的開拓預計將為市場成長提供有利可圖的機會。

全球膽紅素測量儀器產業按產品、適應症、年齡層、最終用戶和地區細分。依產品分類，市場分為台式和經皮型。從適應症來看，可分為黃疸型和肝炎型。依年齡層，分為新生兒和成人。依最終用戶分類，可分為醫院/護理機構、診所等。按地區分類，對北美、歐洲、亞太地區和拉丁美洲地區市場進行了分析。

主要發現

從產品來看，經皮領域將在 2023 年佔據市場佔有率。

有跡象表明，黃疸板塊是2023年的主要股東。

按年齡層別分類，新生兒成為 2023 年的關鍵群體。

從最終用戶來看，醫院和護理機構已成為 2023 年的主要細分市場。

按地區分類，北美在 2023 年獲得最大佔有率，而亞太地區預計在預測期內複合年成長率最高。

該報告可以客製化。

監管指引
根據客戶興趣加入公司簡介
按國家或地區進行的附加分析 – 市場規模和預測
公司簡介的擴充列表
歷史市場資料
主要參與者的詳細資料（Excel格式，包括位置、聯絡資訊、供應商/供應商網路等）

市場概況
北美洲
- 主要市場趨勢和機遇
- 美國膽紅素測量儀器市場
- 加拿大膽紅素測量儀器市場
- 墨西哥膽紅素測量儀器市場
歐洲
- 主要市場趨勢和機遇
- 德國膽紅素測量儀器市場
- 法國膽紅素儀市場
- 英國膽紅素測定儀市場
- 義大利膽紅素測定儀市場
- 西班牙膽紅素測定儀市場
- 其他歐洲國家膽紅素測量儀器市場
亞太地區
- 主要市場趨勢和機遇
- 日本膽紅素測量儀器市場
- 中國膽紅素測量儀器市場
- 澳洲膽紅素計市場
- 印度膽紅素測定儀市場
- 韓國膽紅素測量儀器市場
- 其他亞太膽紅素測量儀器市場
拉丁美洲/中東/非洲
- 主要市場趨勢和機遇
- 巴西膽紅素測量儀器市場
- 沙烏地阿拉伯膽紅素測量儀市場
- 南非膽紅素測量儀器市場
- 其他拉丁美洲/中東/非洲膽紅素測量儀器市場

第9章競爭格局

介紹
關鍵成功策略
10家主要企業產品圖譜
競爭對手儀表板
競爭熱圖
主要企業定位（2023年）

第10章公司簡介

APEL Co. Ltd
Dragerwerk AG And Co. KGaA
Mennen Medical Ltd
Micro Lab Instruments
Ningbo David Medical Device Co. Ltd
Siemens Healthineers AG
Micro Labs Instruments
AVI Healthcare Pvt Ltd
F. Hoffmann-La Roche Ltd.
Koninklijke Philips NV

簡介目錄

Product Code: A324070

The bilirubin meters market was valued at $1.2 billion in 2023, and is projected to reach $2.5 billion by 2033, growing at a CAGR of 7.6% from 2024 to 2033.

Bilirubin meter is a handheld medical device designed to measure the levels of bilirubin in the blood, primarily in newborns. Elevated bilirubin levels can lead to jaundice, a common condition in infants that, if left untreated, can cause serious health issues, including brain damage. These meters provide a non-invasive, quick, and accurate method for monitoring bilirubin levels, enabling early detection and treatment. Thus, they play a critical role in neonatal care, helping healthcare professionals make informed decisions about the need for further testing or interventions.

The growth of the global bilirubin meters market is driven by alarming rise in prevalence of neonatal jaundice and increase in emphasis on early diagnosis and treatment of jaundice in newborns to prevent complications such as kernicterus. According to a study published by Science Direct in January 2024, approximately 1.1 million babies worldwide develop hyperbilirubinemia yearly; over 20 million are at risk of hyperbilirubinemia-related complications. Furthermore, rise in the number of preterm births, which are more susceptible to jaundice, is contributing to the demand for bilirubin meters. This is attributed to the fact that premature infants often require closer monitoring, making bilirubin meters essential in neonatal intensive care units. As per the World Health Organization, approximately 13.4 million preterm births were reported in 2020. Furthermore, rise in government initiatives aimed at reducing infant mortality and improving neonatal health is encouraging the adoption of bilirubin meters, which acts as the key driving force of the global market. Shift toward non-invasive bilirubin meters, which measure bilirubin levels through the skin using transcutaneous methods, is the current trend that is strengthening the growth of the global market. These devices reduce the need for blood draws, making the process less stressful for newborns and more efficient for healthcare providers. Although non-invasive and digital bilirubin meters offer significant benefits, their high cost can be a barrier to adoption, particularly in low-income regions and smaller healthcare facilities, thereby hampering the market growth. In addition, lack of awareness and training among healthcare providers regarding the importance of regular bilirubin monitoring and the use of bilirubin meters acts as a key deterrent factor of the market. On the contrary, manufacturers are focusing on the development of portable and point-of-care bilirubin meters, which are compact, easy to use, and designed for use in various settings, including hospitals, clinics, and even in-home care. Furthermore, innovations in sensor technology are leading to more accurate and reliable bilirubin meters. These advancements include the use of multispectral sensors and algorithms that provide precise measurements, even in infants with darker skin tones, addressing previous limitations of older devices. Such developments are expected to offer lucrative opportunities for the market growth.

The global bilirubin meters industry is segmented into product, indication, age group, end user, and region. By product, the market is divided into bench-top and transcutaneous. On the basis of indication, it is segregated into jaundice and hepatitis. As per age group, it is classified into neonatal and adults. Depending on end user, it is segregated into hospitals & nursing home, clinics, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By product, the transcutaneous segment dominated the market share in 2023.

On the basis of indication, the jaundice segment was the major shareholder in 2023.

As per age group, neonatal emerged as the leading segment in 2023.

Depending on end user, hospitals & nursing home emerged as the leading segment in 2023.

Region wise, North America garnered maximum share in 2023; however, Asia-Pacific is expected to register highest CAGR during the forecast period.

Competition Analysis

Competitive analysis and profiles of the major players in the global bilirubin meters market include APEL Co. Ltd., Dragerwerk AG & Co. KGaA, Mennen Medical Ltd, Micro Lab Instruments, Ningbo David Medical Device Co. Ltd., Siemens Healthineers AG, Micro Labs Instruments, AVI Healthcare Pvt Ltd, F. Hoffmann-La Roche Ltd., and Koninklijke Philips N.V. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.

Additional benefits you will get with this purchase are:

Quarterly Update and* (only available with a corporate license, on listed price)
5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
Free Upcoming Version on the Purchase of Five and Enterprise User License.
16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
Free data Pack on the Five and Enterprise User License. (Excel version of the report)
Free Updated report if the report is 6-12 months old or older.
24-hour priority response*
Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

Regulatory Guidelines
Additional company profiles with specific to client's interest
Additional country or region analysis- market size and forecast
Expanded list for Company Profiles
Historic market data
Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

By Product

Bench-Top
Transcutaneous

By Indication

Jaundice
Hepatitis

By Age Group

Neonatal
Adults

By End User

Hospitals and Nursing Home
Clinics
Others

Key Market Players:

APEL Co. Ltd
Dragerwerk AG & Co. KGaA
Mennen Medical Ltd
Micro Lab Instruments
Ningbo David Medical Device Co. Ltd
Siemens Healthineers AG
Micro Labs Instruments
AVI Healthcare Pvt Ltd
F. Hoffmann-La Roche Ltd.
Koninklijke Philips N.V.

CHAPTER 1: INTRODUCTION

1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

3.1. Market Definition and Scope
3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities

CHAPTER 4: BILIRUBIN METERS MARKET, BY PRODUCT

4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Product
4.2. Bench-Top
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
4.3. Transcutaneous
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country

CHAPTER 5: BILIRUBIN METERS MARKET, BY INDICATION

5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Indication
5.2. Jaundice
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
5.3. Hepatitis
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country

CHAPTER 6: BILIRUBIN METERS MARKET, BY AGE GROUP

6.1. Market Overview
- 6.1.1 Market Size and Forecast, By Age Group
6.2. Neonatal
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
6.3. Adults
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country

CHAPTER 7: BILIRUBIN METERS MARKET, BY END USER

7.1. Market Overview
- 7.1.1 Market Size and Forecast, By End User
7.2. Hospitals And Nursing Home
- 7.2.1. Key Market Trends, Growth Factors and Opportunities
- 7.2.2. Market Size and Forecast, By Region
- 7.2.3. Market Share Analysis, By Country
7.3. Clinics
- 7.3.1. Key Market Trends, Growth Factors and Opportunities
- 7.3.2. Market Size and Forecast, By Region
- 7.3.3. Market Share Analysis, By Country
7.4. Others
- 7.4.1. Key Market Trends, Growth Factors and Opportunities
- 7.4.2. Market Size and Forecast, By Region
- 7.4.3. Market Share Analysis, By Country

CHAPTER 8: BILIRUBIN METERS MARKET, BY REGION

8.1. Market Overview
- 8.1.1 Market Size and Forecast, By Region
8.2. North America
- 8.2.1. Key Market Trends and Opportunities
- 8.2.2. Market Size and Forecast, By Product
- 8.2.3. Market Size and Forecast, By Indication
- 8.2.4. Market Size and Forecast, By Age Group
- 8.2.5. Market Size and Forecast, By End User
- 8.2.6. Market Size and Forecast, By Country
- 8.2.7. U.S. Bilirubin Meters Market
  - 8.2.7.1. Market Size and Forecast, By Product
  - 8.2.7.2. Market Size and Forecast, By Indication
  - 8.2.7.3. Market Size and Forecast, By Age Group
  - 8.2.7.4. Market Size and Forecast, By End User
- 8.2.8. Canada Bilirubin Meters Market
  - 8.2.8.1. Market Size and Forecast, By Product
  - 8.2.8.2. Market Size and Forecast, By Indication
  - 8.2.8.3. Market Size and Forecast, By Age Group
  - 8.2.8.4. Market Size and Forecast, By End User
- 8.2.9. Mexico Bilirubin Meters Market
  - 8.2.9.1. Market Size and Forecast, By Product
  - 8.2.9.2. Market Size and Forecast, By Indication
  - 8.2.9.3. Market Size and Forecast, By Age Group
  - 8.2.9.4. Market Size and Forecast, By End User
8.3. Europe
- 8.3.1. Key Market Trends and Opportunities
- 8.3.2. Market Size and Forecast, By Product
- 8.3.3. Market Size and Forecast, By Indication
- 8.3.4. Market Size and Forecast, By Age Group
- 8.3.5. Market Size and Forecast, By End User
- 8.3.6. Market Size and Forecast, By Country
- 8.3.7. Germany Bilirubin Meters Market
  - 8.3.7.1. Market Size and Forecast, By Product
  - 8.3.7.2. Market Size and Forecast, By Indication
  - 8.3.7.3. Market Size and Forecast, By Age Group
  - 8.3.7.4. Market Size and Forecast, By End User
- 8.3.8. France Bilirubin Meters Market
  - 8.3.8.1. Market Size and Forecast, By Product
  - 8.3.8.2. Market Size and Forecast, By Indication
  - 8.3.8.3. Market Size and Forecast, By Age Group
  - 8.3.8.4. Market Size and Forecast, By End User
- 8.3.9. UK Bilirubin Meters Market
  - 8.3.9.1. Market Size and Forecast, By Product
  - 8.3.9.2. Market Size and Forecast, By Indication
  - 8.3.9.3. Market Size and Forecast, By Age Group
  - 8.3.9.4. Market Size and Forecast, By End User
- 8.3.10. Italy Bilirubin Meters Market
  - 8.3.10.1. Market Size and Forecast, By Product
  - 8.3.10.2. Market Size and Forecast, By Indication
  - 8.3.10.3. Market Size and Forecast, By Age Group
  - 8.3.10.4. Market Size and Forecast, By End User
- 8.3.11. Spain Bilirubin Meters Market
  - 8.3.11.1. Market Size and Forecast, By Product
  - 8.3.11.2. Market Size and Forecast, By Indication
  - 8.3.11.3. Market Size and Forecast, By Age Group
  - 8.3.11.4. Market Size and Forecast, By End User
- 8.3.12. Rest of Europe Bilirubin Meters Market
  - 8.3.12.1. Market Size and Forecast, By Product
  - 8.3.12.2. Market Size and Forecast, By Indication
  - 8.3.12.3. Market Size and Forecast, By Age Group
  - 8.3.12.4. Market Size and Forecast, By End User
8.4. Asia-Pacific
- 8.4.1. Key Market Trends and Opportunities
- 8.4.2. Market Size and Forecast, By Product
- 8.4.3. Market Size and Forecast, By Indication
- 8.4.4. Market Size and Forecast, By Age Group
- 8.4.5. Market Size and Forecast, By End User
- 8.4.6. Market Size and Forecast, By Country
- 8.4.7. Japan Bilirubin Meters Market
  - 8.4.7.1. Market Size and Forecast, By Product
  - 8.4.7.2. Market Size and Forecast, By Indication
  - 8.4.7.3. Market Size and Forecast, By Age Group
  - 8.4.7.4. Market Size and Forecast, By End User
- 8.4.8. China Bilirubin Meters Market
  - 8.4.8.1. Market Size and Forecast, By Product
  - 8.4.8.2. Market Size and Forecast, By Indication
  - 8.4.8.3. Market Size and Forecast, By Age Group
  - 8.4.8.4. Market Size and Forecast, By End User
- 8.4.9. Australia Bilirubin Meters Market
  - 8.4.9.1. Market Size and Forecast, By Product
  - 8.4.9.2. Market Size and Forecast, By Indication
  - 8.4.9.3. Market Size and Forecast, By Age Group
  - 8.4.9.4. Market Size and Forecast, By End User
- 8.4.10. India Bilirubin Meters Market
  - 8.4.10.1. Market Size and Forecast, By Product
  - 8.4.10.2. Market Size and Forecast, By Indication
  - 8.4.10.3. Market Size and Forecast, By Age Group
  - 8.4.10.4. Market Size and Forecast, By End User
- 8.4.11. South Korea Bilirubin Meters Market
  - 8.4.11.1. Market Size and Forecast, By Product
  - 8.4.11.2. Market Size and Forecast, By Indication
  - 8.4.11.3. Market Size and Forecast, By Age Group
  - 8.4.11.4. Market Size and Forecast, By End User
- 8.4.12. Rest of Asia-Pacific Bilirubin Meters Market
  - 8.4.12.1. Market Size and Forecast, By Product
  - 8.4.12.2. Market Size and Forecast, By Indication
  - 8.4.12.3. Market Size and Forecast, By Age Group
  - 8.4.12.4. Market Size and Forecast, By End User
8.5. LAMEA
- 8.5.1. Key Market Trends and Opportunities
- 8.5.2. Market Size and Forecast, By Product
- 8.5.3. Market Size and Forecast, By Indication
- 8.5.4. Market Size and Forecast, By Age Group
- 8.5.5. Market Size and Forecast, By End User
- 8.5.6. Market Size and Forecast, By Country
- 8.5.7. Brazil Bilirubin Meters Market
  - 8.5.7.1. Market Size and Forecast, By Product
  - 8.5.7.2. Market Size and Forecast, By Indication
  - 8.5.7.3. Market Size and Forecast, By Age Group
  - 8.5.7.4. Market Size and Forecast, By End User
- 8.5.8. Saudi Arabia Bilirubin Meters Market
  - 8.5.8.1. Market Size and Forecast, By Product
  - 8.5.8.2. Market Size and Forecast, By Indication
  - 8.5.8.3. Market Size and Forecast, By Age Group
  - 8.5.8.4. Market Size and Forecast, By End User
- 8.5.9. South Africa Bilirubin Meters Market
  - 8.5.9.1. Market Size and Forecast, By Product
  - 8.5.9.2. Market Size and Forecast, By Indication
  - 8.5.9.3. Market Size and Forecast, By Age Group
  - 8.5.9.4. Market Size and Forecast, By End User
- 8.5.10. Rest of LAMEA Bilirubin Meters Market
  - 8.5.10.1. Market Size and Forecast, By Product
  - 8.5.10.2. Market Size and Forecast, By Indication
  - 8.5.10.3. Market Size and Forecast, By Age Group
  - 8.5.10.4. Market Size and Forecast, By End User

CHAPTER 9: COMPETITIVE LANDSCAPE

9.1. Introduction
9.2. Top Winning Strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Top Player Positioning, 2023

CHAPTER 10: COMPANY PROFILES

10.1. APEL Co. Ltd
- 10.1.1. Company Overview
- 10.1.2. Key Executives
- 10.1.3. Company Snapshot
- 10.1.4. Operating Business Segments
- 10.1.5. Product Portfolio
- 10.1.6. Business Performance
- 10.1.7. Key Strategic Moves and Developments
10.2. Dragerwerk AG And Co. KGaA
- 10.2.1. Company Overview
- 10.2.2. Key Executives
- 10.2.3. Company Snapshot
- 10.2.4. Operating Business Segments
- 10.2.5. Product Portfolio
- 10.2.6. Business Performance
- 10.2.7. Key Strategic Moves and Developments
10.3. Mennen Medical Ltd
- 10.3.1. Company Overview
- 10.3.2. Key Executives
- 10.3.3. Company Snapshot
- 10.3.4. Operating Business Segments
- 10.3.5. Product Portfolio
- 10.3.6. Business Performance
- 10.3.7. Key Strategic Moves and Developments
10.4. Micro Lab Instruments
- 10.4.1. Company Overview
- 10.4.2. Key Executives
- 10.4.3. Company Snapshot
- 10.4.4. Operating Business Segments
- 10.4.5. Product Portfolio
- 10.4.6. Business Performance
- 10.4.7. Key Strategic Moves and Developments
10.5. Ningbo David Medical Device Co. Ltd
- 10.5.1. Company Overview
- 10.5.2. Key Executives
- 10.5.3. Company Snapshot
- 10.5.4. Operating Business Segments
- 10.5.5. Product Portfolio
- 10.5.6. Business Performance
- 10.5.7. Key Strategic Moves and Developments
10.6. Siemens Healthineers AG
- 10.6.1. Company Overview
- 10.6.2. Key Executives
- 10.6.3. Company Snapshot
- 10.6.4. Operating Business Segments
- 10.6.5. Product Portfolio
- 10.6.6. Business Performance
- 10.6.7. Key Strategic Moves and Developments
10.7. Micro Labs Instruments
- 10.7.1. Company Overview
- 10.7.2. Key Executives
- 10.7.3. Company Snapshot
- 10.7.4. Operating Business Segments
- 10.7.5. Product Portfolio
- 10.7.6. Business Performance
- 10.7.7. Key Strategic Moves and Developments
10.8. AVI Healthcare Pvt Ltd
- 10.8.1. Company Overview
- 10.8.2. Key Executives
- 10.8.3. Company Snapshot
- 10.8.4. Operating Business Segments
- 10.8.5. Product Portfolio
- 10.8.6. Business Performance
- 10.8.7. Key Strategic Moves and Developments
10.9. F. Hoffmann-La Roche Ltd.
- 10.9.1. Company Overview
- 10.9.2. Key Executives
- 10.9.3. Company Snapshot
- 10.9.4. Operating Business Segments
- 10.9.5. Product Portfolio
- 10.9.6. Business Performance
- 10.9.7. Key Strategic Moves and Developments
10.10. Koninklijke Philips N.V.
- 10.10.1. Company Overview
- 10.10.2. Key Executives
- 10.10.3. Company Snapshot
- 10.10.4. Operating Business Segments
- 10.10.5. Product Portfolio
- 10.10.6. Business Performance
- 10.10.7. Key Strategic Moves and Developments